Fertility Treatment News and Research

RSS

New insight into oocyte chromosome abnormalities

Ovarian stimulation undertaken by women of advanced maternal age receiving fertility treatment may be disrupting the normal pattern of meiosis - a critical process of chromosome duplication followed by two specialised cell divisions in the production of oocytes and sperm - and leading to abnormalities of chromosome copy numbers that result in IVF failure, pregnancy loss or, more rarely, the birth of affected children with conditions such as Down's syndrome, which is caused by the inheritance of three copies of chromosome 21.

4 Jul 2011

LA/hypnosis combination during surgery can aid healing process, reduce drug use and hospital stay time

Using a combination of hypnosis and local anaesthesia (LA) for certain types of surgery can aid the healing process and reduce drug use and time spent in hospital, anaesthesiologists have found. The combination could also help avoid cancer recurrence and metastases, according to new research to be presented today at the European Anaesthesiology Congress in Amsterdam.

13 Jun 2011

NHS directive to fertility clinics

NHS fertility clinics will be ordered to meet their responsibilities and provide adequate levels of IVF treatment, amid growing concerns. There are claims that a “postcode lottery” is reducing couples' chances of having a baby.

5 Jun 2011

New Seattle IVF program cuts expense of women conceiving child with donated egg

A new, first-of-its-kind Seattle in vitro fertilization program can save women 30 percent on the expense of conceiving a child with a donated egg. The cost-savings comes through Seattle Reproductive Medicine's new shared-donor program that lets two women use eggs provided by a single donor.

21 May 2011

IVF causing multiple birth rates fall

Birth rates for IVF twins and triplets have begun to fall in line with government targets aimed at reducing health risks caused by multiple pregnancies. This fall shows the efficacy of the guidelines brought in by the Human Fertilization and Embryology Authority (HFEA) that urged UK fertility clinics to limit multiple births to no more than 24% in 2009/10. Among naturally-conceived babies, only around one in 70 is a twin.

15 May 2011

ESHRE's Guide for CBRC aims to ensure high-quality assisted reproduction treatment

The European Society of Human Reproduction and Embryology is setting the first ever standards in Cross Border Reproductive Care. The safety of patients, gamete donors, surrogates and future children take centre stage in ESHRE's Good Practice Guide for Cross Border Reproductive Care.

22 Apr 2011

Stress & infertility treatment success unrelated: Study

British researchers from Cardiff University looked at 14 studies that included a total of 3,583 women who had undergone fertility treatment and been assessed for anxiety and stress before they began their therapy. They compared women who became pregnant and those who did not and noted that there was no association between emotional distress and the likelihood of becoming pregnant. The results were published in the online edition of British Medical Journal on Feb. 24.

28 Feb 2011

Merck reports GAAP net income of $861 million for 2010

Merck, known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the fourth quarter of $0.88, which excludes purchase accounting adjustments, restructuring costs and merger-related expenses.

4 Feb 2011

Miracle boy born after new infertility therapy

A Lancashire couple Andrew and Louise Riley have been blessed with a “miracle baby boy” thanks to a pioneering new genetic screening process. Elliott Riley was born just after Christmas after the Rileys opted for a relatively new technique called array comparative genomic hybridisation (CGH) after 10 years of infertility treatments. Mrs. Riley, 37, and her husband, 39, said they were delighted to welcome Elliott on December 30.

3 Feb 2011

New data shows Shady Grove Fertility financial programs make testing, treatment more affordable

New data shows Shady Grove Fertility Center's financial programs -- designed to help make infertility testing and treatment more affordable -- helped more than a quarter of patients proceed with treatment in 2010, despite the year's significant economic challenges.

29 Jan 2011

Maternal deaths related to IVF are a key indicator of risks to older women

Although still rare, maternal deaths related to in vitro fertilisation (IVF) are a key indicator of risks to older women, those with multiple pregnancy and those with underlying disease, warn experts in an editorial published on bmj.com today.

28 Jan 2011

IntegraMed acquires Northwest Center for Reproductive Sciences

IntegraMed America, Inc., the leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, announced today that is has acquired Northwest Center for Reproductive Sciences (NCRS).

18 Jan 2011

CE mark approves Vitrolife's SpermFreeze Solution

SpermFreeze Solution, which is used for freeze storage of sperm, has obtained a CE mark and is thereby approved for sales within the European Economic Area.

12 Jan 2011

Shady Grove Fertility and Cade Foundation grant help paralyzed patient and wife deliver healthy baby boy

Shady Grove Fertility Center is pleased to announce the birth of Collin James Sharp, born December 8, 2010 to Jennifer and David Sharp of Richmond, VA. The 7 lb. 15 oz baby boy's birth was made possible through a partnership of Shady Grove Fertility and the Cade Foundation.

11 Jan 2011

Women & Infants Hospital participates in new fertility drug study

The emotional and physical demands on a couple seeking fertility treatment can be daunting. Researchers are constantly on a quest to improve fertility to increase a couple's chances of becoming pregnant in the most time and cost efficient manner.

13 Dec 2010

Study finds infertility treatment does not increase risk of cerebral palsy in IVF/ICSI children

Doctors have known for some time that children born after fertility treatments such as in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) are at increased risk of cerebral palsy. However, it was not known whether this risk was due to the treatment itself, the higher frequency of preterm or multiple births, or a mechanism associated with couples' underlying infertility.

3 Nov 2010

Vitrolife operating income increases 3% to SEK 25 million for January to September 2010

Vitrolife: Growth in local currency was 13 percent. Sales amounted to SEK 217 (207) million, corresponding to an increase of 4 percent in SEK. Operating income before research and development costs increased by 11 percent and amounted to SEK 58 (53) million.

2 Nov 2010

Merck reports $342 million net income for 2010 third quarter

Merck & Co., Inc. today announced financial results for the third quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the third quarter of $0.85, which excludes purchase accounting adjustments, restructuring costs, merger-related expenses and a $950 million legal reserve.

29 Oct 2010

CECOLFES fertility treatment results demonstrate effectiveness of INVOcell cycle process

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, announced today that Dr. Elkin Lucena of the Columbian Fertility and Sterility Center (CECOLFES LTDA) in Bogota, Colombia presented the results of the Center's first 95 fertility treatment cycles utilizing INVO Bioscience's INVOcell for couples with fertility issues at the 66th Annual Meeting of the American Society of Reproductive Medicine (ASRM) in Denver.

28 Oct 2010

Examining genetic material of egg cells may inform about embryos health

Fertility procedures such as in vitro fertilization (IVF) require a couple and the doctor to place the risky bet that the multiple eggs they choose to fertilize will produce an embryo that will thrive in the uterus. Researchers cannot biopsy eggs directly because that would destroy them, but a new discovery by professors at Brown University and Women & Infants Hospital could lead to new insights about how eggs develop and ultimately inform judgments about how the embryos they produce will fare. The idea is to examine the genetic material the egg cells discarded when they were first forming, to see which genes they were expressing.

26 Oct 2010